Answers are grounded in this paper and cite their sources.
Preclinical study reveals fatty acid length determines GLP-1 protraction in vivo, indicating key design principles for long-acting peptide drugs.
We here report a series of derivatives describing the structure-activity relationship around liraglutide, a once-daily human glucagon-like peptide-1 fatty acid derivative, with respect to potency as well as protraction in vivo. The spacer region between the fatty acid and the peptide is mostly important for potency, whereas the fatty acid or fatty acid mimetic is important for both potency and protraction. The length of the fatty acid is the most important parameter for protraction.
No takes yet. Share an insight, caveat, or question.
Madsen et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: